Franklin Street Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Buy
3,408
+131
+4% +$44.8K 0.07% 76
2026
Q1
$1.15M Sell
3,277
-5
-0.2% -$1.78K 0.07% 76
2025
Q4
$1.07M Buy
3,282
+110
+3% +$34.9K 0.06% 78
2025
Q3
$895K Sell
3,172
-206
-6% -$59.7K 0.05% 83
2025
Q2
$943K Sell
3,378
-21,044
-86% -$5.96M 0.06% 83
2025
Q1
$7.61M Sell
24,422
-21,974
-47% -$6.49M 0.54% 51
2024
Q4
$12.1M Sell
46,396
-11,762
-20% -$3.49M 0.8% 41
2024
Q3
$18.7M Buy
58,158
+735
+1% +$240K 1.26% 28
2024
Q2
$17.9M Buy
57,423
+5,513
+11% +$1.62M 1.28% 27
2024
Q1
$14.8M Buy
51,910
+4,826
+10% +$1.41M 1.09% 33
2023
Q4
$13.6M Buy
47,084
+4,101
+10% +$1.12M 1.11% 36
2023
Q3
$11.6M Buy
42,983
+3,455
+9% +$862K 1.02% 37
2023
Q2
$8.78M Buy
39,528
+1,392
+4% +$323K 0.74% 46
2023
Q1
$9.22M Sell
38,136
-325
-0.8% -$79.8K 0.84% 43
2022
Q4
$10.1M Sell
38,461
-1,128
-3% -$302K 0.96% 37
2022
Q3
$8.92M Buy
39,589
+4,174
+12% +$1.01M 0.9% 41
2022
Q2
$8.62M Buy
35,415
+17,196
+94% +$4.21M 0.81% 45
2022
Q1
$4.41M Buy
18,219
+12,844
+239% +$2.95M 0.36% 56
2021
Q4
$1.21M Buy
5,375
+2,714
+102% +$573K 0.09% 76
2021
Q3
$566K Buy
2,661
+11
+0.4% +$2.53K 0.05% 104
2021
Q2
$646K Sell
2,650
-50
-2% -$12.3K 0.05% 97
2021
Q1
$672K Sell
2,700
-192
-7% -$45.8K 0.06% 95
2020
Q4
$665K Sell
2,892
-27
-0.9% -$6.22K 0.06% 91
2020
Q3
$742K Buy
2,919
+227
+8% +$56.2K 0.08% 87
2020
Q2
$635K Sell
2,692
-486
-15% -$111K 0.08% 87
2020
Q1
$644K Sell
3,178
-184
-5% -$40.2K 0.09% 85
2019
Q4
$810K Buy
3,362
+113
+3% +$24.9K 0.1% 85
2019
Q3
$629K Sell
3,249
-166
-5% -$31.9K 0.08% 92
2019
Q2
$629K Sell
3,415
-136
-4% -$24.4K 0.08% 93
2019
Q1
$675K Buy
3,551
+850
+31% +$162K 0.09% 89
2018
Q4
$526K Hold
2,701
0.08% 97
2018
Q3
$560K Hold
2,701
0.08% 96
2018
Q2
$499K Hold
2,701
0.07% 99
2018
Q1
$460K Sell
2,701
-102
-4% -$18.7K 0.07% 101
2017
Q4
$487K Buy
2,803
+102
+4% +$18.1K 0.07% 107
2017
Q3
$504K Buy
2,701
+114
+4% +$20.2K 0.08% 99
2017
Q2
$446K Sell
2,587
-155
-6% -$25.2K 0.08% 103
2017
Q1
$450K Buy
2,742
+305
+13% +$50.7K 0.08% 108
2016
Q4
$356K Sell
2,437
-5
-0.2% -$753 0.06% 137
2016
Q3
$407K Sell
2,442
-20
-0.8% -$3.38K 0.07% 137
2016
Q2
$375K Hold
2,462
0.07% 140
2016
Q1
$369K Hold
2,462
0.07% 155
2015
Q4
$400K Hold
2,462
0.08% 159
2015
Q3
$341K Sell
2,462
-500
-17% -$78.8K 0.07% 170
2015
Q2
$455K Hold
2,962
0.08% 149
2015
Q1
$473K Buy
2,962
+40
+1% +$6.3K 0.09% 141
2014
Q4
$465K Buy
2,922
+60
+2% +$9.35K 0.09% 139
2014
Q3
$402K Hold
2,862
0.08% 172
2014
Q2
$339K Sell
2,862
-12,848
-82% -$1.49M 0.06% 179
2014
Q1
$1.94M Sell
15,710
-2,430
-13% -$295K 0.39% 71
2013
Q4
$2.07M Sell
18,140
-400
-2% -$45.5K 0.42% 69
2013
Q3
$2.08M Sell
18,540
-435
-2% -$47.2K 0.47% 60
2013
Q2
$1.87M Buy
+18,975
New +$1.97M 0.46% 60

Other funds holding AMGN

Franklin Street Advisors's AMGN Position: Q2 2026 in Review

Franklin Street Advisors increased its Amgen (AMGN) stake by 4% in Q2 2026, buying an estimated $44.8K and bringing the position to 3,408 shares worth $1.23M. The position accounts for 0.07% of the portfolio, ranked #76.

Franklin Street Advisors first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $18.7M in Q3 2024. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Franklin Street Advisors held 3,408 shares of Amgen worth $1.23M as of Q2 2026.
  • Franklin Street Advisors bought 131 Amgen shares in Q2 2026, an estimated $44.8K.
  • Amgen made up 0.07% of Franklin Street Advisors's portfolio in Q2 2026, its #76 holding.
  • Franklin Street Advisors first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Franklin Street Advisors's Amgen position peaked at $18.7M in Q3 2024.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Franklin Street Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.